Nightstar Therapeutics plc American Depositary Shares
NITE
NITE was delisted on the 6th of June, 2019.
29 hedge funds and large institutions have $143M invested in Nightstar Therapeutics plc American Depositary Shares in 2017 Q3 according to their latest regulatory filings, with 29 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$54.6M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
+$38.2M |
| 3 |
NMC
NEA Management Company
Timonium,
Maryland
|
+$15.4M |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$11.1M |
| 5 |
BlackRock
New York
|
+$7.02M |
Top Sellers
NITE Hedge Fund Activity: Q3 2017 in Review
29 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Nightstar Therapeutics plc American Depositary Shares (NITE) for Q3 2017, worth a combined $143M.
Buyers outnumbered sellers: 29 funds opened new NITE positions and 0 closed out — a net gain of 29 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Wellington Management Group, opening a new position worth an estimated $54.6M.
- 29 institutional investors held Nightstar Therapeutics plc American Depositary Shares (NITE) as of Q3 2017, up from 0 in Q2 2017.
- Funds reported $143M of Nightstar Therapeutics plc American Depositary Shares stock for Q3 2017.
- 29 funds opened new Nightstar Therapeutics plc American Depositary Shares positions in Q3 2017 and 0 closed out, a net change of +29 holders.
- The largest Nightstar Therapeutics plc American Depositary Shares buyer in Q3 2017 was Wellington Management Group, an estimated $54.6M added.
Based on aggregated 13F filings for Q3 2017.